Structure Therapeutics (GPCR) Change in Acquisitions & Divestments (2022 - 2026)
Quarterly Change in Acquisitions & Divestments rose 0.83% to $151.7 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $631.8 million through Mar 2026, up 36.79% year-over-year, with the annual reading at $630.5 million for FY2025, 82.82% up from the prior year.
Structure Therapeutics' Change in Acquisitions & Divestments history spans 5 years, with the latest figure at $151.7 million for Q1 2026.
- Change in Acquisitions & Divestments came in at $151.7 million for Q1 2026, up from $146.2 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $195.9 million in Q3 2025 to a low of -$92.8 million in Q2 2023.
- The 5-year median for Change in Acquisitions & Divestments is $66.4 million (2024), against an average of $78.8 million.
- The largest YoY upside for Change in Acquisitions & Divestments was 6954.0% in 2023 against a maximum downside of 983.62% in 2023.
- Structure Therapeutics' Change in Acquisitions & Divestments stood at $19.6 million in 2022, then skyrocketed by 190.82% to $57.0 million in 2023, then skyrocketed by 190.35% to $165.5 million in 2024, then fell by 11.68% to $146.2 million in 2025, then grew by 3.79% to $151.7 million in 2026.
- Per Business Quant, the three most recent readings for GPCR's Change in Acquisitions & Divestments are $151.7 million (Q1 2026), $146.2 million (Q4 2025), and $195.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Structure Therapeutics | 8.43 Bn | 8.43 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 151.70 Mn |
| Mar 31, 2026 | 151.70 Mn |
| Dec 31, 2025 | 146.17 Mn |
| Dec 31, 2025 | 146.17 Mn |
| Sep 30, 2025 | 195.92 Mn |
| Sep 30, 2025 | 195.92 Mn |
| Jun 30, 2025 | 138.00 Mn |
| Jun 30, 2025 | 138.00 Mn |
| Mar 31, 2025 | 150.45 Mn |
| Mar 31, 2025 | 150.45 Mn |
| Dec 31, 2024 | 165.50 Mn |
| Dec 31, 2024 | 165.50 Mn |
| Sep 30, 2024 | 66.40 Mn |
| Sep 30, 2024 | 66.40 Mn |
| Jun 30, 2024 | 79.50 Mn |
| Jun 30, 2024 | 79.50 Mn |
| Mar 31, 2024 | 33.50 Mn |
| Mar 31, 2024 | 33.50 Mn |
| Dec 31, 2023 | 57.00 Mn |
| Dec 31, 2023 | 57.00 Mn |
| Sep 30, 2023 | 45.88 Mn |
| Sep 30, 2023 | 45.88 Mn |
| Jun 30, 2023 | -92.78 Mn |
| Jun 30, 2023 | -92.78 Mn |
| Mar 31, 2023 | 141.08 Mn |
| Mar 31, 2023 | 141.08 Mn |
| Dec 31, 2022 | 19.60 Mn |
| Dec 31, 2022 | 19.60 Mn |
| Sep 30, 2022 | 29.40 Mn |
| Sep 30, 2022 | 29.40 Mn |
| Jun 30, 2022 | 10.50 Mn |
| Jun 30, 2022 | 10.50 Mn |
| Mar 31, 2022 | 2.00 Mn |
| Mar 31, 2022 | 2.00 Mn |